FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment ...Middle East

Fortune - News
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult population. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment )

Also on site :



Latest News